Newsletter - September 7, 2012


Published on

Latest Advances in Clinical Senology and Oncology

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide Newsletter - September 7, 2012

  1. 1. Senology Newsletter Page 1 of 3 - Newsletter International Senologic and Oncologic  Scientific Community (ISOSC)  "Connecting specialists worldwide" Editor-in-Chief: Gian Paolo Andreoletti, MD Subscribe Unsubscribe Contact Back Issues Connecting Specialists Worldwide Join us on LinkedIn, ResearchGate, Doctorsbook, Twitter, Facebook, Google Groups, YouTube, SlideShare, Flickr, and share informations and opinions. Check out Newspaper and follow our RSS feeds for real-time updates Literature Selection Sparano JA et al.: "Obesity at diagnosis is associated with inferior outcomes in hormone receptor- positive operable breast cancer", Cancer. 2012 Aug 27 [Epub ahead of print] Niraula S et al.: "Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study", Breast Cancer Res Treat. 2012 Aug 30. [Epub ahead of print] Loibl S et al.: "Treatment of breast cancer during pregnancy: an observational study", Lancet Oncol. 2012 Sep;13(9):887-96 Cuk K et al.: "Circulating microRNAs in plasma as early detection markers for breast cancer", Int J Cancer. 2012 Aug 28 [Epub ahead of print] Autier P et al.: "Mammography screening and breast cancer mortality in Sweden", J Natl Cancer Inst. 2012 Jul 18;104(14):1080-93 Karlsson P et al.: "Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report", Ann Oncol. 2012 Jul 9. [Epub ahead of print] Jeevan R et al.: "Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics", BMJ. 2012 Jul 12;345 e4505 Shah C et al.: "Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ", Clin Breast Cancer. 2012 Aug;12(4):259-63 Comment "Association between night-work and breast cancer risk", Johnni Hansen, Institute of Cancerfile://C:Documents and SettingsutenteDesktopNewsl_Sept2012.htm 07/09/2012
  2. 2. Senology Newsletter Page 2 of 3 Epidemiology, Danish Cancer Society, Copenhagen, Denmark "Our study has the following clinical implications: 1) Overall, this study further strengths the evidence for an association between night-work and breast cancer risk. Now, 10 out of 13 epidemiological studies have supported this link, which was evaluated by the International Agency for Research on Cancer in 2007 as “possibly carcinogenic”. 2) The breast cancer risk seems minimal, if any, for less than 3 consecutive night shifts per week. 3) Diurnal preference seems to be an indicator of breast cancer risk. 4) Especially women with morning preference should avoid or limit night shift work. 5) Further studies are needed and ongoing, also in other potential target organs such as the prostate and colo-rectal. " (Commentary on: Hansen J et al.: "Nested case-control study of night shift work and breast cancer risk among women in the Danish military", Occup Environ Med. 2012 [Epub ahead of print]) Calendar of Events IBUS Update in Breast Imaging, 19 - 22 September 2012, Ferrara, Italy 12th Michelangelo Foundation Seminar: “Moving from adjuvant to neoadjuvant trials for development of new therapies in breast cancer: a hopeless heresy or a feasible paradigm shift?”, October 12, 2012 Milan, Italy 17th World Congress on Breast Diseases of the Senologic International Society, -SIS, October 10-13, 2012, Salvador, Bahia, Brazil Breast Cancer in Young Women Conference, 8-10 November 8-10, 2012, Dublin, Ireland IBUS - International Breast Ultrasound Course, 13 - 15 November 2012, Tel Aviv, Israel 8th Meet the Professor. Advanced International Breast Cancer Conference (AIBCC), November 15-17, 2012, Padova , Italy - under the Patronage of 2012 CTRC-AACR San Antonio Breast Cancer Symposium , December 4-8, 2012, San Antonio, TX, USA Literature Selection Tavani A et al.: "Dietary folates and cancer risk in a network of case-control studies", Ann Oncol. 2012 Aug 16. [Epub ahead of print] Nam JH et al.: "Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence,", Cancer. 2012 Jul 16. doi: 10.1002/cncr.27495. [Epub ahead of print] de Vathaire F et al.: "Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study", Lancet Oncol. 2012 Aug 22. [Epub ahead of print] Levenback CF et al.: "Lymphatic Mapping and Sentinel Lymph Node Biopsy in Women With Squamous Cell Carcinoma of the Vulva: A Gynecologic Oncology Group Study, J Clin Oncol. 2012 Jul 2. [Epub ahead of print] Wilt TJ et al.: "Radical prostatectomy versus observation for localized prostate cancer", N Engl J Med. 2012 Jul 19;367(3):203-13 Heijnsdijk EA et al. : "Quality-of-life effects of prostate-specific antigen screening", N Engl J Med. 2012 Aug 16;367(7):595-605 Choe KS et al.: "Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy", J Clin Oncol. 2012 Aug 27. [Epub ahead of print] Kunath F et al.: "Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: A systematic review", BMC Med. 2012 Aug 28;10 (1):96. [Epub ahead of print] Petrelli F et al.: "Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trials", Ann Oncol. 2012 Jul;23(7):1672-9 Fragments of History 1910 - Discovery of a viral cause of avian cancer by Francis Peyton Rous (Baltimora, October 5, 1879 - New York, February 16, 1970). Rous P. : "A transmissible avian neoplasm (Sarcoma of the common fowl)", J Exp Med. 1910 Sep 1;12(5).696-705 Literature Selectionfile://C:Documents and SettingsutenteDesktopNewsl_Sept2012.htm 07/09/2012
  3. 3. Senology Newsletter Page 3 of 3 Le Ray I et al.: "Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study", Breast Cancer Res Treat. 2012 Sep;135(2):603-9 Nichols HB et al.: "Postoophorectomy Estrogen Use and Breast Cancer Risk", Obstet Gynecol. 2012 Jul;120(1):27-36 collaborates with - "Cancer questions, answers, and support". Follow the Expert Q&A Workshops and join the conversation. Q&A of the month "What are tumorgrafts and how can they help me personalize my cancer treatment? " "Every patient’s cancer is unique. Two patients with the same type of cancer will often respond differently to the same treatment. Tumorgrafts are pieces of living tumor tissue from a specific patient that are implanted (or grafted) into a mouse. Once the patients tumor (graft) begins to grow in the mice, it can be expanded in additional mice and tested against different cancer drugs. The graft can be used to personalize cancer therapy by finding the drug or combination of drugs that works best to shrink the tumor in the mouse. This information can then be used by the treating physician to personalize the patient’s cancer care ." (Answer by David Sidransky, Johns Hopkins Hospital, Baltimore, MD USA) Next Q&A Workshops "Neuro- Oncology", with Lawrence Recht, Stanford Cancer Institute, September 10, 2012 "Uveal melanoma", with William Harbour, University of Miami, September 11, 2012 Stay informed.... Recent Advances in Clinical Medicine Olmes MJ et al.: "Eltrombopag and improved hematopoiesis in refractory aplastic anemia", N Engl J Med. 2012 Jul 5;367(1):11-9 Unsubscribe       www.senology.orgfile://C:Documents and SettingsutenteDesktopNewsl_Sept2012.htm 07/09/2012